isomethyleugenol has been researched along with Peanut Hypersensitivity in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berglund, JP; Bucayu, R; Galli, SJ; Garcia, MA; Ishida, S; Kohli, A; Lyu, SC; Maecker, H; Nadeau, KC; O'Riordan, G; Syed, A; Tsai, M | 1 |
Pearson, H | 1 |
1 trial(s) available for isomethyleugenol and Peanut Hypersensitivity
Article | Year |
---|---|
Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3).
Topics: Administration, Oral; Adolescent; Adult; Antigens; Arachis; Child; Child, Preschool; Dendritic Cells; Desensitization, Immunologic; Double-Blind Method; Female; Forkhead Transcription Factors; Humans; Immune Tolerance; Immunoglobulin E; Immunoglobulin G; Male; Methylation; Middle Aged; Peanut Hypersensitivity; T-Lymphocytes, Regulatory; Young Adult | 2014 |
1 other study(ies) available for isomethyleugenol and Peanut Hypersensitivity
Article | Year |
---|---|
Children of the 90s: Coming of age.
Topics: Adolescent; Age Distribution; Biological Specimen Banks; Child; Family Characteristics; Female; Genome, Human; Health Surveys; Heredity; History, 20th Century; History, 21st Century; Humans; Infant; Longitudinal Studies; Methylation; Obesity; Peanut Hypersensitivity; Pregnancy; Surveys and Questionnaires; United Kingdom; Young Adult | 2012 |